21.60 USD
↗ 0.27 (1.27%)LIVE (AS OF 03:29 PM EDT)
Jade Biosciences, Inc. Common Stock
JBIONASDAQ • USD
Market: OPEN
Jade Biosciences, Inc. Common Stock (JBIO) trades at $21.60 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, JBIO trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 26, 2026.
Open?$21.26
High?$21.85
Low?$21.11
Prev. Close?$21.33
Volume?181.8K
Avg. Volume?802.7K
VWAP?$21.62
Rel. Volume?0.23x
Bid / Ask
Bid?$18.61 × 100
Ask?$21.58 × 100
Spread?$2.97
Midpoint?$20.10
Valuation & Ratios
Market Cap?1.4B
Shares Out?63.6M
Float?41.4M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?3.08
EPS?-$1.93
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Themes
Employees
55
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?24.49Safe
Confidence?38%Very Low
Short InterestSqueeze Risk
Short % of Float?23.33%Squeeze Risk
Short Interest?9.7M
Days to Cover?10.2
Free Float41.4M
Avg Daily Volume951.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?14.93Strong
Quick Ratio?14.93Strong
Cash Ratio?3.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.08FAIR▾
Peers100
S&P55
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-28.0%WEAK▾
S&P6
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-110213000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day